NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 12.47M | 17.26M | 17.05M | 17.50M | 16.63M |
| Total Other Revenue | -- | 1.00K | -- | 1.00K | 1.00K |
| Total Revenue | 12.47M | 17.26M | 17.05M | 17.50M | 16.63M |
| Cost of Revenue | 5.31M | 5.60M | 6.32M | 6.14M | 5.68M |
| Gross Profit | 7.16M | 11.65M | 10.73M | 11.36M | 10.95M |
| SG&A Expenses | 8.72M | 12.63M | 16.71M | 16.92M | 16.58M |
| Depreciation & Amortization | 1.09M | 1.09M | 1.09M | 2.23M | 2.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.48M | 25.99M | 29.28M | 30.47M | 30.79M |
| Operating Income | -5.01M | -8.73M | -12.23M | -12.97M | -14.16M |
| Income Before Tax | -14.93M | -17.58M | -12.17M | -25.96M | -13.67M |
| Income Tax Expenses | 54.00K | -94.00K | 74.00K | -298.00K | -10.00K |
| Earnings from Continuing Operations | -14.99M | -17.49M | -12.24M | -25.66M | -13.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.99M | -17.49M | -12.24M | -25.66M | -13.66M |
| EBIT | -5.01M | -8.73M | -12.23M | -12.97M | -14.16M |
| EBITDA | -175.00K | -7.34M | -10.82M | -11.54M | -12.69M |
| EPS Basic | -1.00 | -2.27 | -1.59 | -3.33 | -1.77 |
| Normalized Basic EPS | -0.39 | -1.43 | -1.02 | -2.09 | -1.11 |
| EPS Diluted | -1.00 | -2.27 | -1.59 | -3.40 | -1.77 |
| Normalized Diluted EPS | -0.39 | -1.43 | -1.02 | -2.09 | -1.11 |
| Average Basic Shares Outstanding | 15.01M | 7.70M | 7.70M | 7.70M | 7.70M |
| Average Diluted Shares Outstanding | 15.01M | 7.70M | 7.70M | 7.70M | 7.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |